On Nov 06, major Wall Street analysts update their ratings for $Astera Labs (ALAB.US)$, with price targets ranging from $100 to $110.
J.P. Morgan analyst Harlan Sur maintains with a buy rating, and adjusts the target price from $70 to $110.
Deutsche Bank analyst Ross Seymore maintains with a buy rating, and adjusts the target price from $60 to $100.
Jefferies analyst Blayne Curtis maintains with a buy rating, and adjusts the target price from $65 to $100.
Evercore analyst Mark Lipacis maintains with a buy rating, and adjusts the target price from $80 to $110.
Needham analyst Quinn Bolton maintains with a buy rating, and adjusts the target price from $65 to $100.
Furthermore, according to the comprehensive report, the opinions of $Astera Labs (ALAB.US)$'s main analysts recently are as follows:
Astera Labs has exhibited a robust increase in revenue this quarter, surpassing the performance in the initial two quarters post-IPO. This uptick is credited to strong sales from GPU platforms, augmented by new ASIC processors and the growth of its second product line. Additionally, there is increasing clarity regarding the anticipated advancements of the third and fourth product lines slated for the latter half of 2025.
Astera Labs has seen another quarter of positive performance attributed to Aries, setting the stage for a promising year ahead, which is expected to be led by Scorpio and Gen 6 developments.
Following 'another impressive beat and raise' in the fourth quarter, analysts continue to recommend buying, as estimates have been increased due to sustained momentum for Aries retimers across both GPU and ASIC programs. The acceleration of 400G deployments for Taurus and the expected ramp-up of Scorpio switch revenues in the second half of 2025, contributing to 10% of overall revenues next year, are also highlighted.
Astera Labs has been recognized for its robust performance in Q3 and an optimistic projection for Q4. The company's revenue trajectory is expected to diversify and maintain high visibility into the year 2025, bolstered by a range of products and increasing content with a diverse customer base.
Here are the latest investment ratings and price targets for $Astera Labs (ALAB.US)$ from 9 analysts:
Note:
TipRanks, an independent third party, provides analysis data from financial analysts and calculates the Average Returns and Success Rates of the analysts' recommendations. The information presented is not an investment recommendation and is intended for informational purposes only.
Success rate is the number of the analyst's successful ratings, divided by his/her total number of ratings over the past year. A successful rating is one based on if TipRanks' virtual portfolio earned a positive return from the stock. Total average return is the average rate of return that the TipRanks' virtual portfolio has earned over the past year. These portfolios are established based on the analyst's preliminary rating and are adjusted according to the changes in the rating.
TipRanks provides a ranking of each analyst up to 5 stars, which is representative of all recommendations from the analyst. An analyst's past performance is evaluated on a scale of 1 to 5 stars, with more stars indicating better performance. The star level is determined by his/her total success rate and average return.
